| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.12 | 0.5 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.11 | 0.5 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |